Skip to main content

Together we are beating cancer

Donate now

Cancer type

Showing 12 out of 2916 results

Overweight women who take regular intense exercise cut their risk of developing endometrial cancer, the most common form of womb cancer, by more than a third (39 per cent) , according to research published in the British Journal of Cancer. Overweight women who take regular intense exercise cut their risk of developing endometrial cancer, the most common form of womb cancer, by more than a third (39 per cent) , according to research published in the British Journal of Cancer.

by British Journal of Cancer | News | 7 August 2013

7 August 2013

Cancer Research UK logo

We take an in-depth look at what brain tumours are, how our knowledge about them is evolving and what this means for tackling brain tumours in the future. We take an in-depth look at what brain tumours are, how our knowledge about them is evolving and what this means for tackling brain tumours in the future.

by Henry Scowcroft | Analysis | 6 August 2013

6 August 2013

Cancer Research UK logo

In the wake of a huge study mapping cancer genetics, new research has linked a tiny bit of genetic material to the immune system and breast cancer. In the wake of a huge study mapping cancer genetics, new research has linked a tiny bit of genetic material to the immune system and breast cancer.

by Kat Arney | Analysis | 5 August 2013

5 August 2013

Forty per cent of UK parents (which equates to around 4.5 million) of children aged 16 or under admit they often forget to protect their skin in strong sun because they are concentrating on protecting their children instead, a new survey by Cancer Research UK and NIVEA SUN reveals today. Forty per cent of UK parents (which equates to around 4.5 million) of children aged 16 or under admit they often forget to protect their skin in strong sun because they are concentrating on protecting their children instead, a new survey by Cancer Research UK and NIVEA SUN reveals today.

by Cancer Research UK | News | 1 August 2013

1 August 2013

Survival for testicular cancer has risen by almost 30 per cent in the last 40 years, with nearly all men now beating the disease latest figures show. Survival for testicular cancer has risen by almost 30 per cent in the last 40 years, with nearly all men now beating the disease latest figures show.

by Cancer Research UK | News | 29 July 2013

29 July 2013

Scientists have discovered a new molecule that prevents cancer cells from responding and surviving when starved of oxygen and which could be developed into new treatments for the disease. Scientists have discovered a new molecule that prevents cancer cells from responding and surviving when starved of oxygen and which could be developed into new treatments for the disease.

by Cancer Research UK | News | 26 July 2013

26 July 2013

More than eight out of 10 people diagnosed with malignant melanoma, the most dangerous form of skin cancer, will now survive the disease, compared to only around five in 10 in the early 70s, according to a new report from Cancer Research UK. More than eight out of 10 people diagnosed with malignant melanoma, the most dangerous form of skin cancer, will now survive the disease, compared to only around five in 10 in the early 70s, according to a new report from Cancer Research UK.

by Cancer Research UK | News | 22 July 2013

22 July 2013

  • Health & Medicine

The story of temozolomide

From its early development in the 1970's to its use as an important treatment for adult brain tumours, we explore the history of the cancer drug temozolomide. From its early development in the 1970's to its use as an important treatment for adult brain tumours, we explore the history of the cancer drug temozolomide.

by Kat Arney | Analysis | 18 July 2013

18 July 2013

This entry is part 13 of 30 in the series Our milestones
%postcontent%
TRACERx-logo

We've announced a huge research project called TRACERx, investing millions of pounds into understanding the genetic driving force behind lung cancer. We've announced a huge research project called TRACERx, investing millions of pounds into understanding the genetic driving force behind lung cancer.

by Henry Scowcroft | Analysis | 18 July 2013

18 July 2013